Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Oct;70(4):684–689. doi: 10.1038/bjc.1994.373

Allele loss on chromosomes 10 and 17p and epidermal growth factor receptor gene amplification in human malignant astrocytoma related to prognosis.

S Leenstra 1, E K Bijlsma 1, D Troost 1, J Oosting 1, A Westerveld 1, D A Bosch 1, T J Hulsebos 1
PMCID: PMC2033395  PMID: 7917918

Abstract

Patients with high-grade astrocytomas have a poor prognosis. However, considerable variation exists within this group of patients with respect to post-operative survival. In order to determine whether genetic alterations might be of help in subdividing this group, we used allele loss on chromosomes 10 and 17p and epidermal growth factor receptor (EGFR) gene amplification in the tumours as genetic parameters and determined their prognostic value. A series of 47 malignant (grade III and grade IV) tumours were genetically characterised, and four types of tumours were found. Type 1 tumours had loss of heterozygosity on chromosome arm 17p (LOH 17p) as the sole genetic alteration. Patients with this type of tumour were relatively young (mean age 39 years) and had a median survival period of 17 months. Type 2 tumours displayed only allele loss on chromosome 10 (LOH 10), type 3 tumours had LOH 10 + LOH 17p and type 4 tumours contained LOH 10 + EGFR gene amplification. Patients with types 2, 3 and 4 tumours were older (mean ages 59, 65 and 54 years respectively) and had a shorter survival (median duration 6, 3 and 2 months respectively) than type 1 patients. Multivariate analysis indicated that the genetic subdivision was a significant prognostic variable. In this study, age proved to be of minor importance with regard to survival. Our study revealed a predominance of frontally located tumours in patients with type 1 tumours, i.e. with LOH 17p only.

Full text

PDF
684

Images in this article

687Figure 2
on p.687

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayoubi S., Walter P. H., Naik S., Sankaran M., Robinson D. Audit in the management of gliomas. Br J Neurosurg. 1993;7(1):61–69. doi: 10.3109/02688699308995057. [DOI] [PubMed] [Google Scholar]
  2. Baker S. J., Preisinger A. C., Jessup J. M., Paraskeva C., Markowitz S., Willson J. K., Hamilton S., Vogelstein B. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 1990 Dec 1;50(23):7717–7722. [PubMed] [Google Scholar]
  3. Bigner S. H., Burger P. C., Wong A. J., Werner M. H., Hamilton S. R., Muhlbaier L. H., Vogelstein B., Bigner D. D. Gene amplification in malignant human gliomas: clinical and histopathologic aspects. J Neuropathol Exp Neurol. 1988 May;47(3):191–205. doi: 10.1097/00005072-198805000-00001. [DOI] [PubMed] [Google Scholar]
  4. Bijlsma E. K., Leenstra S., Westerveld A., Bosch D. A., Hulsebos T. J. Amplification of the anonymous marker D17S67 in malignant astrocytomas. Genes Chromosomes Cancer. 1994 Feb;9(2):148–152. doi: 10.1002/gcc.2870090213. [DOI] [PubMed] [Google Scholar]
  5. Burger P. C., Green S. B. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer. 1987 May 1;59(9):1617–1625. doi: 10.1002/1097-0142(19870501)59:9<1617::aid-cncr2820590916>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  6. Chung R., Whaley J., Kley N., Anderson K., Louis D., Menon A., Hettlich C., Freiman R., Hedley-Whyte E. T., Martuza R. TP53 gene mutations and 17p deletions in human astrocytomas. Genes Chromosomes Cancer. 1991 Sep;3(5):323–331. doi: 10.1002/gcc.2870030502. [DOI] [PubMed] [Google Scholar]
  7. Collins V. P., James C. D. Gene and chromosomal alterations associated with the development of human gliomas. FASEB J. 1993 Jul;7(10):926–930. doi: 10.1096/fasebj.7.10.8344489. [DOI] [PubMed] [Google Scholar]
  8. Curran W. J., Jr, Scott C. B., Horton J., Nelson J. S., Weinstein A. S., Nelson D. F., Fischbach A. J., Chang C. H., Rotman M., Asbell S. O. Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials. J Neurooncol. 1992 Mar;12(3):219–227. doi: 10.1007/BF00172709. [DOI] [PubMed] [Google Scholar]
  9. Daumas-Duport C., Scheithauer B., O'Fallon J., Kelly P. Grading of astrocytomas. A simple and reproducible method. Cancer. 1988 Nov 15;62(10):2152–2165. doi: 10.1002/1097-0142(19881115)62:10<2152::aid-cncr2820621015>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  10. Ekstrand A. J., James C. D., Cavenee W. K., Seliger B., Pettersson R. F., Collins V. P. Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res. 1991 Apr 15;51(8):2164–2172. [PubMed] [Google Scholar]
  11. Feinberg A. P., Vogelstein B. "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum. Anal Biochem. 1984 Feb;137(1):266–267. doi: 10.1016/0003-2697(84)90381-6. [DOI] [PubMed] [Google Scholar]
  12. Frankel R. H., Bayona W., Koslow M., Newcomb E. W. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Cancer Res. 1992 Mar 15;52(6):1427–1433. [PubMed] [Google Scholar]
  13. Fujimoto M., Fults D. W., Thomas G. A., Nakamura Y., Heilbrun M. P., White R., Story J. L., Naylor S. L., Kagan-Hallet K. S., Sheridan P. J. Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme. Genomics. 1989 Feb;4(2):210–214. doi: 10.1016/0888-7543(89)90302-9. [DOI] [PubMed] [Google Scholar]
  14. Fults D., Brockmeyer D., Tullous M. W., Pedone C. A., Cawthon R. M. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res. 1992 Feb 1;52(3):674–679. [PubMed] [Google Scholar]
  15. Fults D., Pedone C. A., Thomas G. A., White R. Allelotype of human malignant astrocytoma. Cancer Res. 1990 Sep 15;50(18):5784–5789. [PubMed] [Google Scholar]
  16. Fults D., Pedone C. Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme. Genes Chromosomes Cancer. 1993 Jul;7(3):173–177. doi: 10.1002/gcc.2870070311. [DOI] [PubMed] [Google Scholar]
  17. Fults D., Tippets R. H., Thomas G. A., Nakamura Y., White R. Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma. Cancer Res. 1989 Dec 1;49(23):6572–6577. [PubMed] [Google Scholar]
  18. Hollstein M., Sidransky D., Vogelstein B., Harris C. C. p53 mutations in human cancers. Science. 1991 Jul 5;253(5015):49–53. doi: 10.1126/science.1905840. [DOI] [PubMed] [Google Scholar]
  19. Hurtt M. R., Moossy J., Donovan-Peluso M., Locker J. Amplification of epidermal growth factor receptor gene in gliomas: histopathology and prognosis. J Neuropathol Exp Neurol. 1992 Jan;51(1):84–90. doi: 10.1097/00005072-199201000-00010. [DOI] [PubMed] [Google Scholar]
  20. James C. D., Carlbom E., Dumanski J. P., Hansen M., Nordenskjold M., Collins V. P., Cavenee W. K. Clonal genomic alterations in glioma malignancy stages. Cancer Res. 1988 Oct 1;48(19):5546–5551. [PubMed] [Google Scholar]
  21. James C. D., Carlbom E., Nordenskjold M., Collins V. P., Cavenee W. K. Mitotic recombination of chromosome 17 in astrocytomas. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2858–2862. doi: 10.1073/pnas.86.8.2858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Karlbom A. E., James C. D., Boethius J., Cavenee W. K., Collins V. P., Nordenskjöld M., Larsson C. Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum Genet. 1993 Sep;92(2):169–174. doi: 10.1007/BF00219686. [DOI] [PubMed] [Google Scholar]
  23. Leenstra S., Troost D., Westerveld A., Bosch D. A., Hulsebos T. J. Molecular characterization of areas with low grade tumor or satellitosis in human malignant astrocytomas. Cancer Res. 1992 Mar 15;52(6):1568–1572. [PubMed] [Google Scholar]
  24. Matlashewski G. J., Tuck S., Pim D., Lamb P., Schneider J., Crawford L. V. Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol. 1987 Feb;7(2):961–963. doi: 10.1128/mcb.7.2.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Matsunami N., Smith B., Ballard L., Lensch M. W., Robertson M., Albertsen H., Hanemann C. O., Müller H. W., Bird T. D., White R. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nat Genet. 1992 Jun;1(3):176–179. doi: 10.1038/ng0692-176. [DOI] [PubMed] [Google Scholar]
  26. Nigro J. M., Baker S. J., Preisinger A. C., Jessup J. M., Hostetter R., Cleary K., Bigner S. H., Davidson N., Baylin S., Devilee P. Mutations in the p53 gene occur in diverse human tumour types. Nature. 1989 Dec 7;342(6250):705–708. doi: 10.1038/342705a0. [DOI] [PubMed] [Google Scholar]
  27. North B., Reilly P., Blumbergs P., Roder D., Esterman A. Malignant astrocytoma in South Australia: treatment and case survival. Med J Aust. 1990 Sep 3;153(5):250–254. doi: 10.5694/j.1326-5377.1990.tb136894.x. [DOI] [PubMed] [Google Scholar]
  28. Pentao L., Wise C. A., Chinault A. C., Patel P. I., Lupski J. R. Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit. Nat Genet. 1992 Dec;2(4):292–300. doi: 10.1038/ng1292-292. [DOI] [PubMed] [Google Scholar]
  29. Ransom D. T., Ritland S. R., Moertel C. A., Dahl R. J., O'Fallon J. R., Scheithauer B. W., Kimmel D. W., Kelly P. J., Olopade O. I., Diaz M. O. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas. Genes Chromosomes Cancer. 1992 Nov;5(4):357–374. doi: 10.1002/gcc.2870050412. [DOI] [PubMed] [Google Scholar]
  30. Rasheed B. K., Fuller G. N., Friedman A. H., Bigner D. D., Bigner S. H. Loss of heterozygosity for 10q loci in human gliomas. Genes Chromosomes Cancer. 1992 Jul;5(1):75–82. doi: 10.1002/gcc.2870050111. [DOI] [PubMed] [Google Scholar]
  31. Revesz T., Scaravilli F., Coutinho L., Cockburn H., Sacares P., Thomas D. G. Reliability of histological diagnosis including grading in gliomas biopsied by image-guided stereotactic technique. Brain. 1993 Aug;116(Pt 4):781–793. doi: 10.1093/brain/116.4.781. [DOI] [PubMed] [Google Scholar]
  32. Salford L. G., Brun A., Nirfalk S. Ten-year survival among patients with supratentorial astrocytomas grade III and IV. J Neurosurg. 1988 Oct;69(4):506–509. doi: 10.3171/jns.1988.69.4.0506. [DOI] [PubMed] [Google Scholar]
  33. Scanlon P. W., Taylor W. F. Radiotherapy of intracranial astrocytomas: analysis of 417 cases treated from 1960 through 1969. Neurosurgery. 1979 Sep;5(3):301–308. [PubMed] [Google Scholar]
  34. Troelstra C., Landsvater R. M., Wiegant J., van der Ploeg M., Viel G., Buys C. H., Hoeijmakers J. H. Localization of the nucleotide excision repair gene ERCC6 to human chromosome 10q11-q21. Genomics. 1992 Apr;12(4):745–749. doi: 10.1016/0888-7543(92)90304-b. [DOI] [PubMed] [Google Scholar]
  35. Venter D. J., Thomas D. G. Multiple sequential molecular abnormalities in the evolution of human gliomas. Br J Cancer. 1991 May;63(5):753–757. doi: 10.1038/bjc.1991.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Watanabe K., Nagai M., Wakai S., Arai T., Kawashima K. Loss of constitutional heterozygosity in chromosome 10 in human glioblastoma. Acta Neuropathol. 1990;80(3):251–254. doi: 10.1007/BF00294641. [DOI] [PubMed] [Google Scholar]
  37. Wong A. J., Bigner S. H., Bigner D. D., Kinzler K. W., Hamilton S. R., Vogelstein B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6899–6903. doi: 10.1073/pnas.84.19.6899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. el-Azouzi M., Chung R. Y., Farmer G. E., Martuza R. L., Black P. M., Rouleau G. A., Hettlich C., Hedley-Whyte E. T., Zervas N. T., Panagopoulos K. Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas. Proc Natl Acad Sci U S A. 1989 Sep;86(18):7186–7190. doi: 10.1073/pnas.86.18.7186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. von Deimling A., Eibl R. H., Ohgaki H., Louis D. N., von Ammon K., Petersen I., Kleihues P., Chung R. Y., Wiestler O. D., Seizinger B. R. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res. 1992 May 15;52(10):2987–2990. [PubMed] [Google Scholar]
  40. von Deimling A., Louis D. N., von Ammon K., Petersen I., Hoell T., Chung R. Y., Martuza R. L., Schoenfeld D. A., Yaşargil M. G., Wiestler O. D. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg. 1992 Aug;77(2):295–301. doi: 10.3171/jns.1992.77.2.0295. [DOI] [PubMed] [Google Scholar]
  41. von Deimling A., von Ammon K., Schoenfeld D., Wiestler O. D., Seizinger B. R., Louis D. N. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol. 1993 Jan;3(1):19–26. doi: 10.1111/j.1750-3639.1993.tb00721.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES